A share price of Rocket Pharmaceuticals Inc [RCKT] is currently trading at $3.37, up 7.67%. An important factor to consider is whether the stock is rising or falling in short-term value. The RCKT shares have gain 19.93% over the last week, with a monthly amount glided 24.81%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Rocket Pharmaceuticals Inc [NASDAQ: RCKT] stock has seen the most recent analyst activity on May 30, 2025, when Evercore ISI downgraded its rating to a In-line but kept the price target unchanged to $5 for it. Previously, Morgan Stanley downgraded its rating to Equal-Weight on May 28, 2025, and kept the price target unchanged to $7. On May 28, 2025, downgrade downgraded it’s rating to Market Perform but maintained its price target of $8 on the stock. JP Morgan downgraded its rating to a Neutral. Jefferies downgraded its rating to a Hold but $2.50 remained the price target by the analyst firm on May 28, 2025. Goldman downgraded its rating to Sell for this stock on May 28, 2025, but kept the price target unchanged to $2. In a note dated May 27, 2025, TD Cowen downgraded an Hold rating on this stock.
Rocket Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $2.19 and $26.98. Currently, Wall Street analysts expect the stock to reach $2.25 within the next 12 months. Rocket Pharmaceuticals Inc [NASDAQ: RCKT] shares were valued at $3.37 at the most recent close of the market. An investor can expect a potential drop of -33.23% based on the average RCKT price forecast.
Analyzing the RCKT fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.65 and Total Capital is -0.62. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.20 points at the first support level, and at 3.02 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.48, and for the 2nd resistance point, it is at 3.58.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Rocket Pharmaceuticals Inc [NASDAQ:RCKT] is 9.19. On the other hand, the Quick Ratio is 9.19, and the Cash Ratio is 1.41.
Transactions by insiders
Recent insider trading involved Ondrey Aaron, Chief Financial Officer, that happened on Jul 03 ’25 when 1477.0 shares were sold. Officer, Ondrey Aaron completed a deal on Jul 03 ’25 to buy 1477.0 shares. Meanwhile, Militello John sold 357.0 shares on May 20 ’25.
